Can a 10-Minute phone test spot ADHD among Look-Alike disorders?
NCT ID NCT07329673
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a digital app called QbMobile that measures attention, impulsivity, and activity levels through two 10-minute tests. Researchers want to see if the app can help distinguish ADHD from conditions like bipolar disorder, autism, depression, and anxiety. About 300 people aged 6 to 60 with suspected or diagnosed versions of these conditions will take the tests at a clinic and at home. The results will not affect their medical care but may lead to better diagnostic tools in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- QbMobile digital software application (investigational device)
- What this could lead to
- If successful, QbMobile could provide doctors with an objective tool to more accurately differentiate ADHD from other conditions with similar symptoms.
- What could go wrong
- This is an early-stage study focused on data collection, not treatment. The test results will not influence diagnosis or care, and it is unclear if the app will prove reliable enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Potential study participants who meet the eligibility criteria will be identified through referrals and recruitment efforts at the participating study sites.
- Ages
-
6 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Provide written informed consent (including parent/legal guardians consent when this is required for individuals under 18 years old and assent as is required based on the age of participant) for QbMobile; * Aged \> 6 years and \< 60 years old; * Referred for an initial assessment for ASD, MDD, Bipolar Disorder or Anxiety Disorder (Separation Anxiety Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder (GAD)) or has a prior diagnosis of one of the included disorders but is not currently receiving treatment; * Meets DSM-5 or ICD-11 criteria for a primary diagnosis of ASD, MDD, Bipolar Disorder or Anxiety Disorder per sites standard clinical procedures; * Have adequate sensory and physical ability to complete QbMobile; * Possess or have access to an iPhone model that supports QbMobile. Exclusion Criteria: * Intellectual disability designated by IQ\<70; * Has a DSM-5 or ICD-11 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, psychotic disorder due to another medical condition, PTSD, antisocial personality disorder, or borderline personality disorder; * Has a primary diagnosis of ADHD (combined, inattentive, or hyperactivity/impulsive presentation); * Has a concurrent medical diagnosis that could significantly affect test performance such as brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g. vascular dementia, Alzheimer disease, etc); * Has other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain); * Use of prescription medications (e.g., anxiolytics, sedative medications) taken on the day before completing QbMobile that could significantly affect performance; * Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autism spectrum disorder (ASD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CCM Clinical Research Group
RECRUITINGMiami, Florida, 33133, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Magnetic brain zaps may quiet anxiety: device trial puts it to the test
- Can a computer game rewire anxious Kids' brains?
- Can an AI chatbot ease the stress of parenting a child with autism or ADHD?
- Do obese children with autism face different heart risks?
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Dance moves may unlock social skills in children with autism